quinoxalines has been researched along with 4-aminopiperidine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernardi, G; Berretta, N; Ledonne, A; Mango, D; Mercuri, NB | 1 |
Audette, NJ; Barth, AL; Matsushita, M; Urban-Ciecko, J | 1 |
2 other study(ies) available for quinoxalines and 4-aminopiperidine
Article | Year |
---|---|
Hippocampus versus entorhinal cortex decoupling by an NR2 subunit-specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Animals; Dose-Response Relationship, Drug; Drug Interactions; Entorhinal Cortex; Excitatory Amino Acid Antagonists; Hippocampus; In Vitro Techniques; Neural Pathways; Patch-Clamp Techniques; Phenols; Piperidines; Potassium Channel Blockers; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2012 |
POm Thalamocortical Input Drives Layer-Specific Microcircuits in Somatosensory Cortex.
Topics: Animals; Channelrhodopsins; Excitatory Amino Acid Antagonists; Inhibitory Postsynaptic Potentials; Mice; Mice, Inbred C57BL; Nerve Net; Neural Pathways; Parvalbumins; Piperidines; Potassium Channel Blockers; Pyramidal Cells; Quinoxalines; Receptors, Serotonin, 5-HT3; Sodium Channel Blockers; Somatosensory Cortex; Somatostatin; Tetrodotoxin; Thalamic Nuclei; Vasoactive Intestinal Peptide | 2018 |